These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4602944)

  • 41. The hazards of using vasoactive drugs to augment peripheral and cerebral blood flow.
    Carey JP; Stemmer EA; List JW; Chin SC; Heber R; Connolly JE
    Am Surg; 1969 Jan; 35(1):12-22. PubMed ID: 5765641
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemodynamic changes after intravenous administration of ajmaline in cardiopathic patients].
    Knippel M; Brusoni B; Cadel A
    Boll Soc Ital Cardiol; 1971; 16(1):47-56. PubMed ID: 5104118
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 45. [Measurements of regional brain blood flow using xenon 133 before and after intravenous administration of the so-called vasoactive and cerebral-metabolism-active drugs in acute experiment].
    Kohlmeyer K
    Verh Dtsch Ges Kreislaufforsch; 1973; 39():96-101. PubMed ID: 4785972
    [No Abstract]   [Full Text] [Related]  

  • 46. Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery.
    Paulson OB
    Neurology; 1970 Jan; 20(1):63-77. PubMed ID: 5460771
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of intracarotid phenoxybenzamine on cerebral blood flow and vasospasm: a clinical study.
    Handa J; Matsuda M; Otsubo K; Handa H
    Surg Neurol; 1973 Jul; 1(4):229-32. PubMed ID: 4732187
    [No Abstract]   [Full Text] [Related]  

  • 48. [Measurement of regional cerebral blood in man by intraarterial xenon-133-injection].
    Pálvölgyi R
    Arch Psychiatr Nervenkr (1970); 1968; 212(1):8-28. PubMed ID: 5733782
    [No Abstract]   [Full Text] [Related]  

  • 49. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
    Baturic P; Cirignotta F
    Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of raubasine in treatment of peripheral arterious circulation disorders].
    Koch G; Eide M
    Med Klin; 1972 Nov; 67(46):1519-21. PubMed ID: 4265445
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of cocarboxylase on cerebral circulation of patients with cerebral arteriosclerosis].
    Eninia GI; Smeltere ES
    Vrach Delo; 1974 Dec; (12):17-20. PubMed ID: 4446520
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of arterial carbon dioxide partial pressure and sevoflurane on capillary venous cerebral blood flow and oxygen saturation during craniotomy.
    Klein KU; Glaser M; Reisch R; Tresch A; Werner C; Engelhard K
    Anesth Analg; 2009 Jul; 109(1):199-204. PubMed ID: 19535711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Report on the treatment of ocular blood circulation disorders with raubasin].
    Genée E
    Med Welt; 1968 Aug; 33():1773-81. PubMed ID: 5712285
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Studies of the administration of ustimon and instenon in cerebrovascular diseases].
    Pichler E; Strauss A
    Wien Klin Wochenschr; 1968 Jan; 80(4):61-4 passim. PubMed ID: 5667714
    [No Abstract]   [Full Text] [Related]  

  • 56. Hemodynamic effects of vasopressin. An experimental study in normovolemic and hypovolemic anesthetized dogs.
    Ericsson BF
    Acta Chir Scand Suppl; 1971; 414():1-29. PubMed ID: 4935762
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cerebral circulatory insufficiency in a new light, with special attention to the results of measurements of regional cerebral circulation].
    Skinhoj E
    Ugeskr Laeger; 1970 Apr; 132(14):667-73. PubMed ID: 5426503
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinico-therapeutic controls of the antihypertensive drugs and compounds effective on the regulation of the regional circulation].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Apr; 57(1):31-48. PubMed ID: 5090284
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemodynamic principles of therapygin cerebrovascular diseases].
    Klein K
    Med Klin; 1973 May; 68(18):572-9. PubMed ID: 4576604
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of angiographic contrast media on regional cerebral blood flow and haemodynamics in man.
    Herrschaft H; Gleim F; Schmidt H
    Neuroradiology; 1974; 7(2):95-103. PubMed ID: 4851729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.